Yongdong Jin

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

Shukui Qin, Stephen L. Chan, Shanzhi Gu et al. · The Lancet · 2023 · 590 citations

First-line Therapy, Hepatology, International Phase 3 +8

Multifunctional nanoparticles as coupled contrast agents

Yongdong Jin, Congxian Jia, Sheng-Wen Huang et al. · Nature Communications · 2010 · 493 citations · Full text

Multifunctional Nanoparticles, Nanoparticles, Functional Nanomaterials +5

Plasmonic fluorescent quantum dots

Yongdong Jin, Xiaohu Gao · Nature Nanotechnology · 2009 · 409 citations · Full text

Plasmonics, Engineering, Physics +3

A High‐Performance Binary Ni–Co Hydroxide‐based Water Oxidation Electrode with Three‐Dimensional Coaxial Nanotube Array Structure

Zhenlu Zhao, Haoxi Wu, Haili He et al. · Advanced Functional Materials · 2014 · 378 citations

Materials Science, Oxide Heterostructures, Chemical Engineering +14

Synthesis of gold nanoplates by aspartate reduction of gold chlorideElectronic supplementary information (ESI) available: Fig. S1. UV/Visible-NIR extinction spectra of an aqueous dispersion of gold nanoparticles synthesized by tyrosine (a), phenylalanine (b), lysine (c), aspartate (d) and tryptophan (e). See http://www.rsc.org/suppdata/cc/b3/b315732f/

Yong Shao, Yongdong Jin, Shaojun Dong · Chemical Communications · 2004 · 318 citations